Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity

BACKGROUND AND PURPOSE: Neurological symptoms have been frequently reported in hospitalized patients with coronavirus disease 2019 (COVID‐19), and biomarkers of central nervous system (CNS) injury are reported to be increased in plasma but not extensively studied in cerebrospinal fluid (CSF). This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Virhammar, Johan, Nääs, Anja, Fällmar, David, Cunningham, Janet L., Klang, Andrea, Ashton, Nicholas J., Jackmann, Sven, Westman, Gabriel, Frithiof, Robert, Blennow, Kaj, Zetterberg, Henrik, Kumlien, Eva, Rostami, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518988/
https://www.ncbi.nlm.nih.gov/pubmed/33369818
http://dx.doi.org/10.1111/ene.14703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518988/
https://www.ncbi.nlm.nih.gov/pubmed/33369818
http://dx.doi.org/10.1111/ene.14703

Ejemplares similares